Holen Sie sich die Stockscreener-App
3.62
6.94%
-0.27
Vorhandelsmarkt:
3.54
-0.08
-2.21%
Schlusskurs vom Vortag:
$3.89
Offen:
$3.87
24-Stunden-Volumen:
60,668
Relative Volume:
0.29
Marktkapitalisierung:
$1.84M
Einnahmen:
$4.70M
Nettoeinkommen (Verlust:
$-4.99M
KGV:
-0.5639
EPS:
-6.42
Netto-Cashflow:
$-5.29M
1W Leistung:
-5.48%
1M Leistung:
-6.94%
6M Leistung:
-65.02%
1J Leistung:
-83.69%
1-Tages-Spanne:
$3.4849
$3.935
1-Wochen-Bereich:
$3.4849
$3.94
52-Wochen-Spanne:
$3.1601
$108.00
Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile
Firmenname
Salarius Pharmaceuticals Inc
Sektor
Branche
Telefon
346-772-0346
Adresse
2450 HOLCOMBE BLVD, HOUSTON
Vergleichen Sie SLRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SLRX
Salarius Pharmaceuticals Inc
|
3.62 | 4.09M | 4.70M | -4.99M | -5.29M | -6.42 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-04-27 | Eingeleitet | Ladenburg Thalmann | Buy |
Salarius Pharmaceuticals Inc Aktie (SLRX) Neueste Nachrichten
How Salarius Pharmaceuticals Inc. (FP10) stock reacts to Fed tighteningQuarterly Portfolio Report & Weekly High Conviction Ideas - newser.com
Analyzing net buyer seller activity in Salarius Pharmaceuticals Inc.2025 Market WrapUp & Free Technical Confirmation Trade Alerts - newser.com
Ranking Salarius Pharmaceuticals Inc. among high performing stocks via tools2025 Volatility Report & Verified Entry Point Detection - newser.com
What risks investors should watch in Salarius Pharmaceuticals Inc. stockPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com
Will Salarius Pharmaceuticals Inc. stock benefit from green energy trends2025 Support & Resistance & Weekly Momentum Picks - newser.com
Applying chart zones and confluence areas to Salarius Pharmaceuticals Inc.2025 Earnings Surprises & Safe Swing Trade Setup Alerts - newser.com
How Salarius Pharmaceuticals Inc. stock benefits from tech adoptionMarket Risk Report & Daily Stock Momentum Reports - newser.com
How Salarius Pharmaceuticals Inc. (FP10) stock moves on employment dataJuly 2025 Update & AI Powered Market Entry Strategies - newser.com
Intraday pattern recognizer results for Salarius Pharmaceuticals Inc.2025 Analyst Calls & Safe Entry Point Identification - newser.com
What’s the recovery path for long term holders of Salarius Pharmaceuticals Inc.Earnings Miss & Safe Swing Trade Setups - newser.com
Can Salarius Pharmaceuticals Inc. (FP10) stock expand revenue streamsMarket Movers & Accurate Buy Signal Notifications - newser.com
What catalysts could drive Salarius Pharmaceuticals Inc. stock higherM&A Rumor & Safe Swing Trade Setups - newser.com
Trend analysis for Salarius Pharmaceuticals Inc. this weekCEO Change & Low Risk High Win Rate Picks - newser.com
Is now a turning point for Salarius Pharmaceuticals Inc.July 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
When is the best time to exit Salarius Pharmaceuticals Inc.July 2025 Reactions & Real-Time Stock Movement Alerts - newser.com
Published on: 2025-11-03 03:25:06 - newser.com
Why Salarius Pharmaceuticals Inc. (FP10) stock stays on top picksQuarterly Earnings Report & Long Hold Capital Preservation Plans - newser.com
Will Salarius Pharmaceuticals Inc. (FP10) stock keep raising dividendsQuarterly Growth Report & Weekly High Return Opportunities - newser.com
Applying Elliott Wave Theory to Salarius Pharmaceuticals Inc.Market Growth Review & AI Driven Stock Reports - newser.com
Technical analysis overview for Salarius Pharmaceuticals Inc. stockQuarterly Profit Summary & Weekly Watchlist of Top Performers - newser.com
Why Salarius Pharmaceuticals Inc. (FP10) stock could break out in 2025July 2025 Summary & Proven Capital Preservation Tips - newser.com
Published on: 2025-11-01 04:32:37 - newser.com
Does Salarius Pharmaceuticals Inc. show high probability of reboundGap Up & High Yield Stock Recommendations - newser.com
How big funds are accumulating Salarius Pharmaceuticals Inc. (FP10) stockJuly 2025 Selloffs & High Yield Equity Trading Tips - newser.com
Salarius Pharmaceuticals Awaits Nasdaq Compliance Confirmation - MSN
How institutional ownership impacts Salarius Pharmaceuticals Inc. stockJuly 2025 PostEarnings & Reliable Momentum Entry Alerts - newser.com
Finanzdaten der Salarius Pharmaceuticals Inc-Aktie (SLRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):